NCT06690125

Brief Summary

The primary aim of this study is to investigate whether multisensory integration (MSI) mechanisms observed in patients with right hemisphere lesions without neglect remain intact compared to patients with Unilateral Spatial Neglect (USN). This study also allows for a direct comparison between results from paper-based tests and computerized tests, as well as between patients with right hemisphere lesions without neglect and USN patients. The secondary objectives are: To compare these results in order to obtain a more refined definition of USN at both the unisensory level (as computerized tests are rarely used in hospital settings but have proven effective in diagnosing USN) and the multisensory level (since USN is not generally tested in the auditory modality). To measure eye movements in all patients in the study, as this can provide useful information for characterizing patient deficits.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Nov 2018

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 7, 2018

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 26, 2020

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 2, 2021

Completed
3.2 years until next milestone

First Submitted

Initial submission to the registry

October 30, 2024

Completed
16 days until next milestone

First Posted

Study publicly available on registry

November 15, 2024

Completed
Last Updated

November 15, 2024

Status Verified

November 1, 2018

Enrollment Period

1.9 years

First QC Date

October 30, 2024

Last Update Submit

November 12, 2024

Conditions

Keywords

neglectattentionawarenessmultisensory integration

Outcome Measures

Primary Outcomes (2)

  • Multisensory Computerized Test

    The test is structured into three tasks that characterize the patient's deficits through visual and auditory stimuli. In Task 1, 100 light items are presented in two blocks of 50, while in Task 2, the patient interacts with 36 sound items in a single block. During these tasks, the patient, seated in front of the computer, must localize the sources of light and sound. The lights are generated on the screen using software like MATLAB, while sounds come from speakers mounted on the screen. The patient's responses are recorded via a microphone and noted by the experimenter using the keyboard.

    The assessment is conducted within a week of admission to the ward.

  • Multisensory Computerized Test

    In Task 3, the presentation occurs simultaneously, with 360 items distributed across 12 blocks of 30 items each, repeated over three days. In this case as well, the patient must localize the sources of light and sound. This integrated approach allows for a thorough evaluation of sensory localization abilities and analyzes the interaction between visual and auditory stimuli in the patient.

    Is conducted over a total of three different days, during which the patient will complete Task 3 in three separate sessions, one for each day.

Secondary Outcomes (7)

  • Mini Mental State Examination (MMSE)

    The assessment is conducted within a week of admission to the ward.

  • Apple Cancellation Test

    The assessment is conducted within a week of admission to the ward.

  • Line Bisection Test

    The assessment is conducted within a week of admission to the ward.

  • Catherine Bergego Scale (CBS)

    The assessment is conducted within a week of admission to the ward.

  • Visual neglect test

    The assessment is conducted within a week of admission to the ward.

  • +2 more secondary outcomes

Study Arms (2)

Patients with right hemisphere stroke (Without USN)

Diagnostic Test: Classical and computerized assessment

Patients with right hemisphere stroke (With USN)

Diagnostic Test: Classical and computerized assessment

Interventions

Patients with right hemisphere stroke will undergo a battery of standardized paper-based tests, as part of routine clinical practice, including cognitive assessments. Additionally, they will complete computerized tests involving the presentation of unisensory (Auditory or Visual Stimuli) and multisensory stimuli (visual and auditory stimuli)

Patients with right hemisphere stroke (With USN)Patients with right hemisphere stroke (Without USN)

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with stroke who have right hemisphere lesions and showed USN.

You may qualify if:

  • Patients will be included in the study if they have:
  • Right hemisphere stroke
  • Presence of USN assessed through the Apple Cancellation
  • Age between 18 and 85 years
  • Signed informed consent
  • Both male and female participants
  • As a control group, patients will also be included if they have:
  • Right hemisphere stroke
  • Absence of USN assessed through the Apple Cancellation
  • Age between 18 and 85 years
  • Signed informed consent
  • Both male and female participants.

You may not qualify if:

  • Both patients with USN and control patients will be excluded if they:
  • Are minors
  • Are unable to give their consent to participate in the study
  • Have significant language deficits (production and comprehension) (e.g., unable to give a verbal response or understand instructions)
  • Have hemianopia
  • Have severe hearing impairments that cannot be corrected (e.g., with hearing aids)
  • Have severe uncorrected visual impairments (e.g., glaucoma)
  • Have a history of psychiatric disorders or substance abuse.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Azienda Ospedaliera Universitaria Integrata Verona - UOC di Neuroriabilitazione

Verona, verona, Italy

Location

MeSH Terms

Conditions

Perceptual DisordersStroke

Condition Hierarchy (Ancestors)

Neurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor

Study Record Dates

First Submitted

October 30, 2024

First Posted

November 15, 2024

Study Start

November 7, 2018

Primary Completion

September 26, 2020

Study Completion

September 2, 2021

Last Updated

November 15, 2024

Record last verified: 2018-11

Locations